IBKR Q1 2026 Earnings EPS Misses Estimates Stock Declines Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones ARWR Q1 2026 Earnings Adjusted Loss Narrows Shares Rise on Surprise Beat AIT Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Higher FDP Q1 2026 Earnings Slight EPS Beat Amid Quiet Revenue Disclosure BLK Q1 2026 Earnings Strong EPS Beat Driven by Fee Income and Asset Growth